{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:15:09Z","timestamp":1791234909443,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/inf.0b013e3182a11808","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T11:27:23Z","timestamp":1372418843000},"page":"1308-1312","source":"Crossref","is-referenced-by-count":53,"title":["Invasive Pneumococcal Disease Among Children With and Without Sickle Cell Disease in the United States, 1998 to 2009"],"prefix":"10.1097","volume":"32","author":[{"given":"Amanda B.","family":"Payne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Link-Gelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma","family":"Azonobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Craig","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard W.","family":"Beall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billie","family":"Juni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1473-3099(10)70055-4","article-title":"Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis.","volume":"10","author":"Ramakrishnan","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/EDE.0b013e3181d61af8","article-title":"Sickle cell trait, hemoglobin C trait, and invasive pneumococcal disease.","volume":"21","author":"Poehling","year":"2010","journal-title":"Epidemiology"},{"issue":"suppl","key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/infdis\/136.Supplement.S25","article-title":"Sickle cell anemia and severe infections due to encapsulated bacteria.","volume":"136","author":"Pearson","year":"1977","journal-title":"J Infect Dis"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/S0022-3476(03)00331-7","article-title":"Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.","volume":"143","author":"Adamkiewicz","year":"2003","journal-title":"J Pediatr"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1542\/peds.106.5.965","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group.","volume":"106","author":"OBrien","year":"2000","journal-title":"Pediatrics"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jpeds.2008.09.052","article-title":"Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002.","volume":"154","author":"Yanni","year":"2009","journal-title":"Journal Pediatr"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Active Bacterial Core SurveillanceEmerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/pbc.23259","article-title":"Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure.","volume":"58","author":"McCavit","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2010.11.025","article-title":"Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure.","volume":"158","author":"McCavit","year":"2011","journal-title":"J Pediatr"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/jir052","article-title":"Shifting genetic structure of invasive serotype 19A pneumococci in the United States.","volume":"203","author":"Beall","year":"2011","journal-title":"J Infect Dis"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3201\/eid0701.010114","article-title":"Active Bacterial Core Surveillance Team of the Emerging Infections Program Network. Active bacterial core surveillance of the emerging infections program network.","volume":"7","author":"Schuchat","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/593339","article-title":"Active Bacterial Core Surveillance Team. Differential effects of pneumococcal vaccines against serotypes 6A and 6C.","volume":"198","author":"Park","year":"2008","journal-title":"J Infect Dis"},{"issue":"suppl 4","key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S.","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mrdd.20124","article-title":"National evaluation of US newborn screening system components.","volume":"12","author":"Therrell","year":"2006","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease.","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/516781","article-title":"Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.","volume":"44","author":"Halasa","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/pbc.22461","article-title":"Susceptibility to invasive bacterial infections in children with sickle cell disease.","volume":"55","author":"Battersby","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1542\/peds.106.2.362","article-title":"Committee on Infectious Diseases. . Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.","volume":"106","year":"2000","journal-title":"Pediatrics"},{"key":"R30-2-20210202","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1016\/j.vaccine.2011.06.056","article-title":"The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.","volume":"29","author":"Cooper","year":"2011","journal-title":"Vaccine"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000207485.39112.bf","article-title":"Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.","volume":"25","author":"Herz","year":"2006","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e3182a11808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:12:41Z","timestamp":1620954761000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201312000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3182a11808","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}